Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

A medical device company whose innovation improves bariatric surgery procedures has secured a $175,000 angel investment from Country Roads Angel Network (CRAN), the state’s only accredited angel investment network. CRAN invests in projects spanning all 55 counties of West Virginia.

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device. McFadden has a track record of launching new medical devices and has worked with industry-leading companies such as Johnson & Johnson and Philips Healthcare. Dr. Szoka is a bariatric surgeon who will lead clinical development of the product. Earlier in 2021, this team secured a licensing agreement from West Virginia University to begin to position the product for commercial use.

Szoka’s invention — currently called the “Endolumik System” — is a fluorescent version of the spacing calibration tubes used in bariatric surgery. When used with a near-infrared compatible camera, the product allows surgeons to see where exactly in the stomach the tubes are so they can avoid that area during the procedure.

Country Roads Angel Network Chairman, Kevin Combs, said CRAN investors are “enthusiastic about the market advantage offered by Endolumik’s new patent-protected device in the fast-growing bariatric surgery space. CRAN is pleased to build on our mission to stimulate West Virginia’s economy by investing in our best and brightest.”

Judy Moore, managing director of CRAN, said the Endolumik investment stems from a partnership recently finalized with Intermed Labs LLC, a Morgantown-based innovation lab and startup studio affiliated with Mon Health System. “We are convinced that other startups and businesses focusing on health innovation and enhanced patient care will follow Endolumik.”

Endolumik, Inc. also recently won the 2021 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Shark Tank, an innovation pitch competition that was held in Las Vegas.

CRAN operates under the umbrella of the New River Gorge Regional Development Authority (NRGRDA), which serves four counties in southern West Virginia and is administered by the West Virginia Hive, a 12-county entrepreneurial support program of the NRGRDA. CRAN is made up of investors largely native to the Mountain State who now are scattered across the country. Members are dedicated to the betterment of West Virginia and hope their investments will generate various levels of positive impact.

Combs said CRAN has heard pitches from entrepreneurs throughout West Virginia and continues to see interesting and exciting opportunities at every review. “We are in negotiations with entrepreneurs now that, if closed, would expand CRAN’s investment portfolio to companies located in a number of regions of our state,” he added.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”